# A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium

> **NCT00224510** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 120 (actual)

## Conditions studied

- Bipolar Disorder
- Bipolar Depression

## Interventions

- **DRUG:** lamotrigine

## Key facts

- **NCT ID:** NCT00224510
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224510, "A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00224510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*